ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
eCl@ss:
32160702
UNSPSC Code:
12352203
NACRES:
NA.41
Conjugate:
unconjugated
Clone:
P4H2, monoclonal
Application:
ICC, WB
Citations:
-
biological source
mouse
Quality Segment
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
P4H2, monoclonal
species reactivity
human
technique(s)
immunocytochemistry: suitable, western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
ambient
target post-translational modification
unmodified
Gene Information
human ... DUX4(100288687)
General description
Double homeobox protein 4 (UniProt Q9UBX2; also known as Double homeobox protein 10) is encoded by the DUX4 (also known as DUX10) gene (Gene ID 100288687) in human. DUX4 is a double homeobox transcription factor that is normally expressed in the testis. Contraction or hypomethylation of D4Z4 macrosatellite repeats on chromosome 4q35 causes aberrant DUX4 expression in skeletal muscle, a hallmark of the incurable disease facioscapulohumeral muscular dystrophy (FSHD), characterized by skeletal muscle weakness and wasting. Gene expression data analysis identifies β-catenin as the main coordinator of FSHD-associated perturbation of protein interaction signallings, including those of canonical Wnt, HIF1-α and TNF-α. In addition, DUX4 expression causes proteolytic degradation of UPF1, a central component of the nonsense-mediated decay (NMD) machinery, and accumulation NMD substrate RNAs including DUX4 mRNA, such that NMD downregulation by DUX4 expression stabilizes DUX4 mRNA through a double-negative feedback loop in FSHD muscle cells. FSHD muscle expresses a low abundance DUX4 mRNA that produces the full-length DUX4 protein. In contrast to control skeletal muscle and most other somatic tissues, full-length DUX4 transcript and protein is expressed at relatively abundant levels in human testis, most likely in the germ-line cells. Induced pluripotent (iPS) cells also express full-length DUX4 and differentiation of iPS cells to embryoid bodies suppresses expression of full-length DUX4, whereas expression of full-length DUX4 persists in differentiated FSHD iPS cells.
~60/45 kDa observed. 44.94 kDa calculated. The larger-than-calculated target band size is consistent with that reported in the literature (Geng, L.N., et al. (2011). Hybridoma (Larchmt). 30(2):125-130; Snider, L., et al. (2010). PLoS Genet. 6(10):e1001181). Uncharacterized bands may be observed in some lysate(s).
Immunogen
GST-tagged recombinant human DUX4 C-terminal fragment.
Application
Detect DUX4 using this mouse monoclonal Anti-DUX4 Antibody, clone P4H2, Cat. No. MABS1348, validated for use in Immunocytochemistry and Western Blotting.
Research Category
Signaling
Signaling
Western Blotting Analysis: 1 µg/mL from a representative lot detected DUX4 in 10 µg of human heart and ovary tissue lysates.
Immunocytochemistry Analysis: A representative lot detected full-length DUX4 (DUX4-FL) nuclear immunoreactivity at a higher frequency among differentiated CD56+ myogenic cells from facioscapulohumeral dystrophy (FSHD) than non-FSHD individuals (Jones, T.I., et al. (2012). Hum. Mol. Genet. 21(20):4419-4430).
Immunocytochemistry Analysis: A representative lot detected exogenously expressed full-length human DUX4 (DUX4-FL) in 2% paraformaldehyde-fixed and 1% Triton X-100-permeabilized C2C12 mouse myoblasts (Geng, L.N., et al. (2011). Hybridoma (Larchmt). 30(2):125-130).
Immunocytochemistry Analysis: A representative lot and another DUX4 antibody that targets an N-terminal region epitope co-stained full-length DUX4 (DUX4-FL) in the nucleus in ~0.1% of cultured facioscapulohumeral dystrophy (FSHD) muscle cells fixed with 2% paraformaldehyde and permeabilized with 1% Triton X-100 (Snider, L., et al. (2010). PLoS Genet. 6(10):e1001181).
Western Blotting Analysis: A representative lot detected exogenously expressed human DUX4, but not DUX4c, in transfected C2C12 mouse myoblasts. No target band was detected in lysate from untransfected cells (Geng, L.N., et al. (2011). Hybridoma (Larchmt). 30(2):125-130).
Western Blotting Analysis: A representative lot detected DUX4 immunoprecipitated from human testis tissue lysate by another DUX4 antibody that targets an N-terminal region epitope (Snider, L., et al. (2010). PLoS Genet. 6(10):e1001181).
Immunocytochemistry Analysis: A representative lot detected full-length DUX4 (DUX4-FL) nuclear immunoreactivity at a higher frequency among differentiated CD56+ myogenic cells from facioscapulohumeral dystrophy (FSHD) than non-FSHD individuals (Jones, T.I., et al. (2012). Hum. Mol. Genet. 21(20):4419-4430).
Immunocytochemistry Analysis: A representative lot detected exogenously expressed full-length human DUX4 (DUX4-FL) in 2% paraformaldehyde-fixed and 1% Triton X-100-permeabilized C2C12 mouse myoblasts (Geng, L.N., et al. (2011). Hybridoma (Larchmt). 30(2):125-130).
Immunocytochemistry Analysis: A representative lot and another DUX4 antibody that targets an N-terminal region epitope co-stained full-length DUX4 (DUX4-FL) in the nucleus in ~0.1% of cultured facioscapulohumeral dystrophy (FSHD) muscle cells fixed with 2% paraformaldehyde and permeabilized with 1% Triton X-100 (Snider, L., et al. (2010). PLoS Genet. 6(10):e1001181).
Western Blotting Analysis: A representative lot detected exogenously expressed human DUX4, but not DUX4c, in transfected C2C12 mouse myoblasts. No target band was detected in lysate from untransfected cells (Geng, L.N., et al. (2011). Hybridoma (Larchmt). 30(2):125-130).
Western Blotting Analysis: A representative lot detected DUX4 immunoprecipitated from human testis tissue lysate by another DUX4 antibody that targets an N-terminal region epitope (Snider, L., et al. (2010). PLoS Genet. 6(10):e1001181).
Biochem/physiol Actions
Clone P4H2 is specific to DUX4 (UniProt Q9UBX2) and does not recognize DUX4c (DUX4L9; UniProt Q6RFH8) or the spliced DUX4 short isoform DUX4-s (UniProt E2JJS1) that lacks the C-terminal epitope region targeted by clone P4H2 (Geng, L.N., et al. (2011). Hybridoma (Larchmt). 30(2):125-130; Snider, L., et al. (2010). PLoS Genet. 6(10):e1001181).
Physical form
Format: Purified
Protein G purified
Purified mouse IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
Stable for 1 year at 2-8°C from date of receipt.
Analysis Note
Evaluated by Western Blotting in human testis tissue lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected DUX4 in 10 µg of human testis tissue lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected DUX4 in 10 µg of human testis tissue lysate.
Other Notes
Concentration: Please refer to lot specific datasheet.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Still not finding the right product?
製品選択ツール}で選択肢を絞り込んでください。
保管分類
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
MABS1348:
jan
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。